Funding, Members Embassy House 8/19/25 Funding, Members Embassy House 8/19/25 Anocca Raises SEK 440 Million to Advance T-Cell Therapy Development Anocca AB, a clinical-stage T-cell immunotherapy company based in Sweden, has raised approximately SEK 440 million (USD 46 million) in new financing. Read More
Funding, Members Embassy House 8/19/25 Funding, Members Embassy House 8/19/25 Anocca Raises SEK 440 Million to Advance T-Cell Therapy Development Anocca AB, a clinical-stage T-cell immunotherapy company based in Sweden, has raised approximately SEK 440 million (USD 46 million) in new financing. Read More
